A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19

被引：0
|
作者：
Zervos, Marcus [1 ,2 ]
Arshad, Samia [1 ]
Kilgore, Paul [2 ,3 ]
Chaudhry, Zohra S. [1 ]
Jacobsen, Gordon [4 ]
Wang, Dee Dee [5 ]
Huitsing, Kylie [1 ,2 ]
Brar, Indira [1 ,2 ]
Alangaden, George J. [1 ]
Ramesh, Mayur S. [1 ]
McKinnon, John E. [1 ]
O'Neill, William [5 ]
机构：
[1] Henry Ford Hosp, Infect Dis, Detroit, MI 48202 USA
[2] Wayne State Univ, Sch Med, Detroit, MI USA
[3] Wayne State Univ, Eugene Applebaum Coll Pharm, Detroit, MI USA
[4] Henry Ford Hosp, Publ Hlth Sci, Detroit, MI 48202 USA
[5] Henry Ford Hosp, Div Cardiovasc Dis & Struct Heart, Detroit, MI 48202 USA
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2020年 / 99卷
关键词：
D O I：
10.1016/j.ijid.2020.07.059
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [1] Hydroxychloroquine in the prevention of COVID-19 mortality
    Jorge, April
    LANCET RHEUMATOLOGY, 2021, 3 (01): : E2 - E3
  • [2] Does hydroxychloroquine reduce mortality for COVID-19?
    Gallus, Silvano
    Clavenna, Antonio
    Lugo, Alessandra
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 82 : 21 - 22
  • [3] Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
    Mohammad Bahadoram
    Bijan Keikhaei
    Ali Saeedi-Boroujeni
    Mohammad-Reza Mahmoudian-Sani
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 997 - 1001
  • [4] Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
    Bahadoram, Mohammad
    Keikhaei, Bijan
    Saeedi-Boroujeni, Ali
    Mahmoudian-Sani, Mohammad-Reza
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (05) : 997 - 1001
  • [5] Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
    Albani, Filippo
    Fusina, Federica
    Giovannini, Alessia
    Ferretti, Pierluigi
    Granato, Anna
    Prezioso, Chiara
    Divizia, Danilo
    Sabaini, Alessandra
    Marri, Marco
    Malpetti, Elena
    Natalini, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 10
  • [6] Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
    José M. Añón
    Jesús Villar
    Intensive Care Medicine, 2021, 47 : 355 - 356
  • [7] The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
    Yaseen M. Arabi
    George P. Chrousos
    G. Umberto Meduri
    Intensive Care Medicine, 2020, 46 : 2067 - 2070
  • [8] The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
    Arabi, Yaseen M.
    Chrousos, George P.
    Meduri, G. Umberto
    INTENSIVE CARE MEDICINE, 2020, 46 (11) : 2067 - 2070
  • [9] Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
    Anon, Jose M.
    Villar, Jesus
    INTENSIVE CARE MEDICINE, 2021, 47 (03) : 355 - 356
  • [10] Hydroxychloroquine and COVID-19
    Sinha, Neeraj
    Balayla, Galit
    POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1139) : 550 - 555
12345